World Health Organization, 1997. Amoebiasis. Wkly Epidemiol Rec 72: 97– 100.
Haque R, Huston CD, Hughes M, Houpt E, Petri WA, 2003. Current concepts: amebiasis. N Engl J Med 348: 1565– 1573.
Pillai DR, Keystone JS, Sheppard DC, MacLean JD, MacPherson DW, Kain KC, 1999. E. histolytica and E. dispar: epidemiology and comparison of diagnostic methods in setting of nonendemicity. Clin Infect Dis 29: 1315– 1318.
Caballero-Salcedo A, Viveros-Rogerl M, Salvaltierra B, Tapia-Conyer R, Sepulveda-Amor J, Gutierrez G, Ortiz-Ortiz L, 1994. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg 50: 412– 419.
Roy S, Kabir M, Mondal D, Ali IK, Petri WA, Haque R, 2005. Real-time PCR assay for diagnosis of Entamoeba histolytica infection. J Clin Microbiol 43: 2168– 2172.
Haque R, Mollah NU, Ali KM, Eubanks A, Lyerly D, Petri WA, 2000. Diagnosis of amebic liver abscess and intestinal infection with the TechLab Entamoeba histolytica II antigen detection and anti-body tests. J Clin Microbiol 38: 3235– 3239.
Petri WA, Snodgrass TL, Jackson TF, Gathiram V, Simjee AE, Chadee K, Kain KC, 1990. Monoclonal antibodies directed against the galactose-binding lectin of Entamoeba histolytica enhance adherence. J Immunol 144: 4803– 4809.
Leo M, Haque R, Kabir M, Roy S, Lahlou RM, Mondal D, Tannich E, Petri WA, 2006. Evaluation of Entamoeba histolytica antigen and antibody point-of-care tests for the rapid diagnosis of amebiasis. J Clin Microbiol 44: 4569– 4571.
Walsh J, 1986. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Clin Infect Dis 8: 228– 238.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||693||126||1|
Amebiasis is a major cause of morbidity and mortality in the developing world. A reliable point-of-care test would help to improve diagnosis and early treatment. We evaluated a novel rapid fecal antigen detection test for E. histolytica (E. HISTOLYTICA QUIK CHEK; TechLab, Inc., Blacksburg, VA), in a cohort of children in Bangladesh where amebiasis is endemic. This point-of-care test had a sensitivity of 100% and a specificity of 100% when compared with enzyme-linked immunosorbent assay antigen detection.
Financial support: This study was supported by National Institutes of Health grant AI 43596 to William A. Petri, Jr. Dr. Petri receives licensing fees from TechLab, Inc. for amebiasis diagnostics; these fees are donated in their entirety to the American Society of Tropical Medicine and Hygiene. This study was also supported by National Institutes of Health grant 5R42AI058450 to Joel F. Herbein.
Authors' addresses: Poonum S. Korpe and William A. Petri Jr., University of Virginia Health System, Carter Harrison Building, Charlottesville, VA, E-mails: firstname.lastname@example.org and email@example.com. Blake R. Stott and Joel F. Herbein, TechLab, Inc., Blacksburg, VA, E-mails: firstname.lastname@example.org and email@example.com. Forida Nazib, Mamun Kabir, and Rashidul Haque, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, E-mails: firstname.lastname@example.org, email@example.com, and firstname.lastname@example.org.